# OnCo record paper-radiant-3-everolimus-pnet-yao-nejm-2011 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-radiant-3-everolimus-pnet-yao-nejm-2011/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-radiant-3-everolimus-pnet-yao-nejm-2011" ;
  schema:name "RADIANT-3: everolimus for advanced pancreatic neuroendocrine tumours"@en ;
  schema:description "The mTOR inhibitor everolimus more than doubled the time to progression in advanced pancreatic neuroendocrine tumours, becoming one of the first two targeted drugs approved for the disease in 2011."@en ;
  schema:url <https://onco.cc/key-papers/paper-radiant-3-everolimus-pnet-yao-nejm-2011/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1009290>, <https://pubmed.ncbi.nlm.nih.gov/21306238/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1009290> ;
  schema:datePublished "2011"^^xsd:gYear ;
  schema:author "Yao JC, Shah MH, Ito T, et al." ;
  onco:cancers <https://onco.cc/cancers/pancreatic-net/> ;
  onco:drugs <https://onco.cc/drugs/everolimus/> ;
  onco:journals <https://onco.cc/journals/nejm/> .